Evidence map›Paper›PMID 31760934›Full record

ArticleBMC bioinformatics2019

Identifying Alzheimer's disease-related proteins by LRRGD.

Tianyi Zhao, Yang Hu, Tianyi Zang, Liang Cheng

Abstract readEvaluation Study
In one paragraph

Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Identifying Protein Biomarkers in Blood for Alzheimer's Disease.Frontiers in cell and developmental biology · 2020
    Article
  9. Identifying Cancer-Related lncRNAs Based on a Convolutional Neural Network.Frontiers in cell and developmental biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tianyi ZhaoSchool of Life Science and Technology, Department of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.
Yang HuSchool of Life Science and Technology, Department of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.
Tianyi ZangSchool of Life Science and Technology, Department of Computer Science and Technology, Harbin Institute of Technology, Harbin, China. tianyi.zang@hit.edu.cn.
Liang ChengCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150001, China. liangcheng@hrbmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlzheimer's disease (AD) imposes a heavy burden on society and every family. Therefore, diagnosing AD in advance and discovering new drug targets are crucial, while these could be achieved by identifying AD-related proteins. The time-consuming and money-costing biological experiment makes researchers turn to develop more advanced algorithms to identify AD-related proteins.

resultsFirstly, we proposed a hypothesis "similar diseases share similar related proteins". Therefore, five similarity calculation methods are introduced to find out others diseases which are similar to AD. Then, these diseases' related proteins could be obtained by public data set. Finally, these proteins are features of each disease and could be used to map their similarity to AD. We developed a novel method 'LRRGD' which combines Logistic Regression (LR) and Gradient Descent (GD) and borrows the idea of Random Forest (RF). LR is introduced to regress features to similarities. Borrowing the idea of RF, hundreds of LR models have been built by randomly selecting 40 features (proteins) each time. Here, GD is introduced to find out the optimal result. To avoid the drawback of local optimal solution, a good initial value is selected by some known AD-related proteins. Finally, 376 proteins are found to be related to AD.

conclusionThree hundred eight of three hundred seventy-six proteins are the novel proteins. Three case studies are done to prove our method's effectiveness. These 308 proteins could give researchers a basis to do biological experiments to help treatment and diagnostic AD.

Indexed as

AlgorithmsAlzheimer DiseaseComputational BiologyDatabases, ProteinHumansProteinsProteinsAlzheimer’s diseaseGradient descentLogistic regressionProteinsSimilarity of diseases

Identifiers

PMID31760934
PMCPMC6876080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.